HYTNF and HYTN Related Headlines

Go Back

May 7, 2026 05:00PM HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils

Apr 30, 2026 05:01PM HYTN Successfully Exports GMP-Manufactured Vape Cartridges

Apr 24, 2026 05:01PM HYTN Announces Extension of Marketing Program

Apr 23, 2026 05:01PM HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business

Apr 17, 2026 05:00PM HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

Mar 27, 2026 06:46PM HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder

Mar 20, 2026 05:30PM HYTN appoints Fabian Monaco to board of directors

Mar 20, 2026 05:30PM HYTN Appoints Fabian Monaco to Board of Directors

Mar 2, 2026 05:00PM HYTN Announces Extension of Marketing Program

Jan 9, 2026 05:00PM HYTN Announces Engagement of Marketing and Communications Services Provider

Dec 18, 2025 05:01PM HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III

Jul 14, 2025 08:00AM HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines

HYTNF and HYTN Related Press Releases

Go Back

May 7, 2026 05:00PM HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils

Apr 30, 2026 05:01PM HYTN Successfully Exports GMP-Manufactured Vape Cartridges

Apr 24, 2026 05:01PM HYTN Announces Extension of Marketing Program

Apr 23, 2026 05:01PM HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business

Apr 17, 2026 05:00PM HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

Mar 27, 2026 06:46PM HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder

Mar 20, 2026 05:30PM HYTN Appoints Fabian Monaco to Board of Directors

Mar 2, 2026 05:00PM HYTN Announces Extension of Marketing Program

Jan 9, 2026 05:00PM HYTN Announces Engagement of Marketing and Communications Services Provider

Dec 18, 2025 05:01PM HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III

Jul 14, 2025 08:00AM HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines

HYTNF and HYTN Related SEC Filings

Go Back